Carna Biosciences Competitors and Similar CompaniesClear all
Carna Biosciences's competitors and similar companies include Takeda, Kyowa Kirin, H3 Biomedicine and Sunesis Pharmaceuticals.
 Carna Biosciences Carna Biosciences (カルナバイオサイエンス株式会社) is a clinical-stage biopharmaceutical company that develops small molecule drugs and provides drug discovery services. |  Takeda Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products. |  Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. |  Sunesis Pharmaceuticals Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers. | ||
Founding Date | Founding Date 2003 | Founding Date 1781 | Founding Date 2008 | Founding Date 2011 | Founding Date 1987 |
Type | Type Public | Type Public | Type Public | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Kobe, JP HQ Natick, US | Locations Cambridge, US HQ | Locations South San Francisco, US HQ | ||
Employees | Employees 65 | Employees 47,4554% decrease | Employees 5,669 | Employees 378% decrease | Employees 42 |
Valuation ($) | Valuation ($) 38.4 m | Valuation ($) 43.7 b | Valuation ($) 8.8 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) ¥579.1m (FY, 2025) | Revenue (est.) ¥4.6t (FY, 2025) | Revenue (est.) ¥496.8b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥190.9m (FY, 2025) | Cost of goods ¥818.8b (FY, 2025) | Cost of goods ¥114.3b (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit ¥388.1m (FY, 2025) | Gross profit ¥3.8t (FY, 2025) | Gross profit ¥383.4b (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income (¥2.2b) (FY, 2025) | Net income ¥108.1b (FY, 2025) | Net income ¥67b (FY, 2025) | Net income N/A | Net income ($114.8m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 57.8m | Total funding raised N/A | Total funding raised $ 200m | Total funding raised $ 171.7m |
For sources of this data, please see the company profile
View Company Profiles
Takeda
HQ
Tokyo, JP
Employees
47,455↓ 4% decrease
Takeda Pharmaceutical (武田薬品工業株式会社) is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
View companyKyowa Kirin
HQ
Tokyo, JP
Employees
5,669
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company
H3 Biomedicine
HQ
Cambridge, US
H3 Biomedicine is a biopharmaceutical company that specializes in cancer genomics.
View companySunesis Pharmaceuticals
HQ
South San Francisco, US
Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.
View company